We are live on ! Find out more
SIM

Spark Investment Management Portfolio holdings

AUM $41.6M
1-Year Est. Return 80.97%
This Fund
S&P 500
This Quarter Est. Return
+2.75%
1 Year Est. Return
+80.97%
3 Year Est. Return
+336.74%
5 Year Est. Return
+318.26%
10 Year Est. Return
+1,447.76%
AUM
$716M
AUM Growth
-$455K
Cap. Flow
+$5.83M
Cap. Flow %
0.81%
Top 10 Hldgs %
9.92%
Holding
851
New
153
Increased
123
Reduced
163
Closed
191

Sector Composition

Rank Sector Weight
1 Technology 20.73%
2 Healthcare 19.83%
3 Consumer Discretionary 15.89%
4 Industrials 11.34%
5 Energy 7.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SVM
626
Silvercorp Metals
SVM
$2.53B
$58K 0.01%
55,000
-20,000
-27% -$24.1K
TST
627
DELISTED
TheStreet, Inc.
TST
$57K 0.01%
3,150
-540
-15% -$10K
BONT
628
DELISTED
Bon-Ton Stores Inc/The
BONT
$56K 0.01%
+12,200
New +$77.4K
CLUB
629
DELISTED
Town Sports International Holdings, Inc.
CLUB
$54K 0.01%
19,200
-9,300
-33% -$43.2K
BEBE
630
DELISTED
Bebe Stores Inc
BEBE
$54K 0.01%
+2,740
New +$77.3K
CFRX
631
DELISTED
ContraFect Corporation
CFRX
$53K 0.01%
13
-24
-65% -$97.3K
PLPM
632
DELISTED
Planet Payment, Inc
PLPM
$51K 0.01%
21,200
MITK icon
633
Mitek Systems
MITK
$835M
$49K 0.01%
+13,200
New +$45.2K
ERII icon
634
Energy Recovery
ERII
$443M
$44K 0.01%
+16,500
New +$48.4K
VXRT
635
DELISTED
Vaxart
VXRT
$40K 0.01%
+1,800
New +$44.2K
EXFO
636
DELISTED
EXFO INC.
EXFO
$39K 0.01%
12,200
-3,800
-24% -$13K
SKBI
637
DELISTED
SKYSTAR BIO-PHARMACEUTICAL CO COM PAR $.001 (NV)
SKBI
$39K 0.01%
15,000
-2,000
-12% -$6.85K
VCEL icon
638
Vericel Corp
VCEL
$2.31B
$37K 0.01%
+10,600
New +$36.3K
ANAD
639
DELISTED
ANADIGICS INC
ANAD
$35K ﹤0.01%
+49,500
New +$51.1K
ACUR
640
DELISTED
Acura Pharmaceuticals
ACUR
$34K ﹤0.01%
+7,040
New +$29.2K
ENVI
641
DELISTED
ENVIVIO INC COM STK (DE)
ENVI
$32K ﹤0.01%
+17,200
New +$30.9K
PLX icon
642
Protalix BioTherapeutics
PLX
$198M
$31K ﹤0.01%
1,620
TLRA
643
DELISTED
Telaria, Inc.
TLRA
$31K ﹤0.01%
+10,800
New +$29.4K
NAUH
644
DELISTED
National American University Holdings, Inc.
NAUH
$31K ﹤0.01%
10,700
CBAY
645
DELISTED
Cymabay Therapeutics
CBAY
$30K ﹤0.01%
11,300
-49,000
-81% -$201K
WTT
646
DELISTED
Wireless Telecom Group, Inc.
WTT
$27K ﹤0.01%
12,900
RSYS
647
DELISTED
Radisys Corp
RSYS
$27K ﹤0.01%
+10,700
New +$26.3K
MERU
648
DELISTED
MERU NETWORKS INC COM STK (DE)
MERU
$26K ﹤0.01%
16,300
-20,300
-55% -$29.9K
TLOG
649
DELISTED
TetraLogic Pharmaceuticals Corporation
TLOG
$25K ﹤0.01%
+11,100
New +$34.2K
SMT
650
DELISTED
SMART TECHNOLOGIES INC COM NEW
SMT
$24K ﹤0.01%
2,580

Similar funds

Spark Investment Management's Q2 2015 Portfolio in Review

As of Q2 2015, Spark Investment Management held 851 positions worth $716M, down 0.06% from $716M the previous quarter. Its ten largest holdings account for 9.9% of the portfolio.

Spark Investment Management's Q2 2015 filing shows 153 new, 123 increased, 163 reduced and 191 closed positions. Its largest new stake was bluebird bio: 2,779 shares worth $6.06M. The largest sale was ARUBA NETWORKS, INC., an estimated $5.17M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Spark Investment Management's largest Q2 2015 buy was bluebird bio: 2,779 shares worth $6.06M.
  • Spark Investment Management added most to Gigamon Inc. in Q2 2015, an estimated $4.46M increase.
  • Spark Investment Management's biggest Q2 2015 reduction was Larimar Therapeutics, cutting an estimated $2.88M.
  • Spark Investment Management fully exited ARUBA NETWORKS, INC. in Q2 2015, selling an estimated $5.17M.
  • Spark Investment Management's ten largest holdings make up 9.9% of its $716M portfolio in Q2 2015.
  • Spark Investment Management opened 153 new positions and closed 191 in Q2 2015.
  • Spark Investment Management's portfolio value fell 0.06% quarter-over-quarter to $716M.

Based on Spark Investment Management's 13F filing for Q2 2015, filed 12 Aug 2015.